Høyer M - Search Results

1

Variations in magnitude and directionality of respiratory target motion throughout full treatment courses of stereotactic body radiotherapy for tumors in the liver.

Worm ES, Høyer M, Fledelius W, Hansen AT, Poulsen PR. Worm ES, et al. Among authors: hoyer m. Acta Oncol. 2013 Oct;52(7):1437-44. doi: 10.3109/0284186X.2013.813638. Epub 2013 Jul 23. Acta Oncol. 2013. PMID: 23879645

2

Radical hysterectomy in cervical carcinoma stage Ib.

Høyer M, Ljungstroem B, Nyland M, Jakobsen A. Høyer M, et al. Eur J Gynaecol Oncol. 1990;11(1):13-7. Eur J Gynaecol Oncol. 1990. PMID: 2347330

3

Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation.

Hansen O, Overgaard J, Hansen HS, Overgaard M, Höyer M, Jörgensen KE, Bastholt L, Berthelsen A. Hansen O, et al. Among authors: hoyer m. Radiother Oncol. 1997 Apr;43(1):47-51. doi: 10.1016/s0167-8140(97)01904-x. Radiother Oncol. 1997. PMID: 9165136 Clinical Trial.

4

Association between in vivo iododeoxyuridine labeling, MIB-1 expression, malignancy grade and clinical stage in human prostate cancer.

Borre M, Høyer M, Sørensen FB, Nerstrøm B, Overgaard J. Borre M, et al. Among authors: hoyer m. APMIS. 1998 Mar;106(3):389-95. doi: 10.1111/j.1699-0463.1998.tb01362.x. APMIS. 1998. PMID: 9548428

5

Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.

Alsner J, Høyer M, Sørensen SB, Overgaard J. Alsner J, et al. Among authors: hoyer m. Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):519-25. doi: 10.1016/s0360-3016(00)01489-9. Int J Radiat Oncol Biol Phys. 2001. PMID: 11173149

6

Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer.

Fokdal L, Honoré H, Høyer M, Meldgaard P, Fode K, von der Maase H. Fokdal L, et al. Among authors: hoyer m. Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):436-44. doi: 10.1016/j.ijrobp.2003.10.039. Int J Radiat Oncol Biol Phys. 2004. PMID: 15145160

7

Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer.

Fokdal L, Høyer M, von der Maase H. Fokdal L, et al. Among authors: hoyer m. Acta Oncol. 2004;43(8):749-57. doi: 10.1080/02841860410018629. Acta Oncol. 2004. PMID: 15764221

8

Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma.

Hoyer M, Roed H, Sengelov L, Traberg A, Ohlhuis L, Pedersen J, Nellemann H, Kiil Berthelsen A, Eberholst F, Engelholm SA, von der Maase H. Hoyer M, et al. Radiother Oncol. 2005 Jul;76(1):48-53. doi: 10.1016/j.radonc.2004.12.022. Radiother Oncol. 2005. PMID: 15990186 Clinical Trial.

9

Comparison of two dose calculation methods applied to extracranial stereotactic radiotherapy treatment planning.

Traberg Hansen A, Petersen JB, Høyer M, Christensen JJ. Traberg Hansen A, et al. Among authors: hoyer m. Radiother Oncol. 2005 Oct;77(1):96-8. doi: 10.1016/j.radonc.2005.04.018. Radiother Oncol. 2005. PMID: 16246744 Clinical Trial.

10

Radical radiotherapy for urinary bladder cancer: treatment outcomes.

Fokdal L, Høyer M, von der Maase H. Fokdal L, et al. Among authors: hoyer m. Expert Rev Anticancer Ther. 2006 Feb;6(2):269-79. doi: 10.1586/14737140.6.2.269. Expert Rev Anticancer Ther. 2006. PMID: 16445379 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results